Work

Efficacy and Safety Comparison Between the DPP-4 Inhibitor Vildagliptin and the Sulfonylurea Gliclazide After Two Years of Monotherapy in Drug-naïve Patients with Type 2 Diabetes

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Hormone and Metabolic Research

DOI: 10.1055/s-0029-1234042

Authors: J. E. Foley, S. Sreenan

Institutions: Novartis (United States), Royal College of Surgeons in Ireland

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1982067008

FWCI: 7.829

Cites:

Cited by: 105

Related to: 10